A new therapeutic approach to <i>KRAS</i> mutant non-small cell lung cancer: the emerging role of exportin 1 inhibition. [PDF]
von Itzstein MS, Gerber DE.
europepmc +1 more source
Exportin 1 inhibitor KPT‑330 reverses oxaliplatin resistance via p53 nuclear retention in colorectal cancer. [PDF]
Lai C +9 more
europepmc +1 more source
Exportin-1 functions as an adaptor for transcription factor-mediated docking of chromatin at the nuclear pore complex. [PDF]
Ge T +13 more
europepmc +1 more source
Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors through ERK1/2 nuclear export. [PDF]
Daneshmandi S +13 more
europepmc +1 more source
Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma. [PDF]
DeSisto JA +14 more
europepmc +1 more source
Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer. [PDF]
Liu XL +9 more
europepmc +1 more source
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer. [PDF]
von Itzstein MS +15 more
europepmc +1 more source
Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. [PDF]
Sekihara K +13 more
europepmc +1 more source
Inhibition of exportin-1 function results in rapid cell cycle-associated DNA damage in cancer cells. [PDF]
Burke RT, Marcus JM, Orth JD.
europepmc +1 more source

